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Functional evidence suggests that nitric oxide released from
CA1 pyramidal cells can act as a retrograde messenger to
mediate hippocampal long-term potentiation, but the failure to
find neuronal nitric oxide synthase (NOS-I) in the dendritic
spines of these cells has cast doubt on this suggestion. We
hypothesized that NOS-I may be in spines but in a form inac-
cessible to antibody when using standard histological fixation
procedures. Supporting this hypothesis, we found that after a
weak fixation protocol shown previously to enhance staining of
synaptic proteins, CA1 pyramidal cells exhibit clear immunore-
activity for NOS-I. Confocal microscopy revealed that numer-
ous dendritic spines in the stratum radiatum contained the NR2
subunit of the NMDA receptor and the adaptor protein postsyn-
aptic density-95, and a subset of these spines also contained
NOS-I. Quantitative studies showed that only 8% of synaptic
puncta (identified by synaptophysin staining) were associated
with NOS-I, and 9% contained the  subunit of soluble
guanylyl cyclase (sGC), a major target of NO. However, the
majority of NOS-I-positive synaptic puncta was associated with
sGC and vice versa. Postembedding immunogold electron mi-
croscopy showed that NOS-I concentrates just inside the
postsynaptic plasma membrane of asymmetric axospinous
synapses in the stratum radiatum of CA1, whereas sGC con-
centrates just inside the presynaptic membrane. Together,
these findings support the possibility that NO may act as a
retrograde messenger to help mediate homosynaptic plasticity
in a subpopulation of synapses in the stratum radiatum of CA1.
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Long-term potentiation (LTP) in the stratum radiatum of the
CA1 field of the hippocampus requires concurrent presynaptic
activity and postsynaptic calcium entry via NMDA receptors
(Bliss and Collingridge, 1993; Nicoll and Malenka, 1995). The
increased efficacy of potentiated synapses presumably involves
local biochemical changes. Accumulating evidence demonstrates
that changes in postsynaptic AMPA receptors contribute to LTP
(Malenka and Nicoll, 1999; Malinow et al., 2000; Soderling and
Derkach, 2000; Sheng and Lee, 2001). However, increased effi-
cacy of presynaptic transmitter release may also contribute to
LTP (Stevens and Wang, 1994; Malgaroli et al., 1995; Choi et al.,
2000; Ganguly et al., 2000; Zakharenko et al., 2001). If postsyn-
aptic Ca2 entry can increase transmitter release, a postsynapti-
cally generated message must act retrogradely at a presynaptic
locus. Of the various molecules proposed as retrograde messen-
gers in CA1 pyramidal neurons (Bazan et al., 1997; Schuman,
1997), perhaps the best known candidate is nitric oxide (NO)
(Holscher, 1997; Haley, 1998; Prast and Philippu, 2001).
Several laboratories have shown that NO may contribute to
hippocampal LTP, at least under certain experimental conditions
(Arancio et al., 1996; Haley et al., 1996; Haley, 1998; Hawkins et
al., 1998; Zorumski and Izumi, 1998). NO is generated by the
oxidation of arginine, a reaction catalyzed by nitric oxide syn-
thase (NOS) (Moncada et al., 1991; Bredt and Snyder, 1994).
NOS isoforms normally found in the brain include the calcium-
dependent enzymes NOS-I (or nNOS, the neuronal isoform) and
NOS-III (or eNOS, the endothelial isoform) (Forstermann et al.,
1991). NOS-III is found in the vascular endothelium; it was
reported also in hippocampal neurons (Dinerman et al., 1994;
O’Dell et al., 1994), but failure to confirm the finding (Chiang et
al., 1994; Weinberg et al., 1994) has led many to doubt this
conclusion. NOS-I is expressed by hippocampal interneurons,
although its presence in CA1 pyramidal cells remains somewhat
controversial (Bredt et al., 1991; Vincent and Kimura, 1992;
Valtschanoff et al., 1993a; Dun et al., 1994; Wendland et al., 1994;
Lin and Totterdell, 1998). Biochemical data show that NOS-I can
bind to the postsynaptic scaffold molecule PSD-95, forming a
complex with the NMDA receptor (Brenman et al., 1996; Chris-
topherson et al., 1999). Consistent with these in vitro data, several
laboratories have reported ultrastructural evidence for NOS-I at
axospinous synapses (Aoki et al., 1993; Faber-Zuschratter and
Wolf, 1994; Faber-Zuschratter et al., 1996; Aoki et al., 1997;
Sancesario et al., 2000; Valtschanoff and Weinberg, 2001).
A principal mediator of signal transduction by NO is soluble
guanylyl cyclase (sGC) (Zabel et al., 1998; Denninger and Mar-
letta, 1999; Koesling, 1999; Wedel and Garbers, 2001), also im-
plicated in some forms of LTP (Boulton et al., 1995; Son et al.,
1998; Lu et al., 1999; Arancio et al., 2001). sGC comprises an 
subunit and a smaller heme-containing  subunit. Heterodimers
are activated by NO binding to the heme moiety, whereas ho-
modimers exhibit little or no cGMP synthetic activity, even in the
presence of NO (Zabel et al., 1999). Despite its role as a principal
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target for NO, little is yet known about the distribution of sGC in
the brain (Burgunder and Cheung, 1994; Burette et al., 2001a;
Ibarra et al., 2001)
Using light microscopic immunocytochemical methods opti-
mized to detect synaptic antigens, we here report that NOS-I and
sGC associate with each other at a subpopulation of synaptic
puncta. Using postembedding immunogold electron microscopy
in the stratum radiatum of CA1, we find that NOS-I lies within the
postsynaptic density of asymmetric axospinous synapses (consis-
tent with previous studies), whereas sGC concentrates in axon
terminals; moreover, the anatomical relationship between presyn-
aptic sGC and postsynaptic NOS is spatially precise. These results
provide neuroanatomical support for the hypothesis that NO can
act as a synapse-specific retrograde messenger in CA1.
MATERIALS AND METHODS
Antisera. Antibodies used in this study are listed in Table 1. We used a
1-specific antibody to probe for sGC. 1 is the predominant  subunit of
sGC in the brain; because homodimers are enzymatically inactive (Zabel
et al., 1998), and because a linear relationship is observed between the
amounts of 1 and 1 in different brain regions (Ibarra et al., 2001), we
consider 1 to be a suitable proxy for overall levels of sGC enzyme. We
initially considered the NOS-I antibody likely to be specific because its
general pattern of staining resembled that for a better characterized
antibody and for staining with NADPH diaphorase (NADPHd), a his-
tochemical marker for NOS (Dawson et al., 1991; Hope et al., 1991;
Schmidt et al., 1992). To provide more compelling evidence for its
specificity, we compared immunolabeling on tissue from NOS-I knock-
out mice and genetically matched controls. The other antibodies used in
this study are well characterized and commercially available
(Valtschanoff et al., 1999; Burette et al., 2001a).
Tissue preparation. All procedures related to the care and treatment of
animals were in accordance with institutional and National Institutes of
Health guidelines. Ten male Sprague Dawley rats (200–350 gm; Charles
River, Raleigh, NC) and eight male mice (7–10 weeks of age; The
Jackson Laboratory, Bar Harbor, ME), including four NOS-I knock-out
mice (strain B6129S-Nos1tm1P1h) and four matched controls (strain
B6129SF2/J), were used for this study. After inducing deep anesthesia
with sodium pentobarbital (60 mg/kg, i.p.), rats were intracardially per-
fused with heparinized saline, followed by 500 ml of fixative; for mice, we
used 25–50 ml of fixative. For LM, some animals were fixed according to
standard protocols, using 4% freshly depolymerized paraformaldehyde
in phosphate buffer (PB; 0.1 M, pH 7.4); brains were removed and
postfixed overnight at 4°C in the same fixative. To assess whether limited
antibody access consequent to aldehyde cross-linking may influence
results, we tested the effects of weak fixation, perfusing five rats and two
mice with 1% paraformaldehyde, followed by a saline flush. For EM,
animals were fixed with a mixture of 4% paraformaldehyde and 0.1–2%
glutaraldehyde in PB. Brains were sectioned at 40–60 m on a Vi-
bratome and collected in cold PB.
LM immunocytochemistry. For immunoperoxidase, free-floating sec-
tions were permeabilized with 50% ethanol for 30 min and treated for 30
min with 3% H2O2 in PBS (0.1 M, pH 7.4) to quench endogenous
peroxidase activity. They were then preincubated in 10% normal donkey
serum (to block secondary antibody binding sites). Sections were incu-
bated in primary antibody (NOS-I or sGC; 1:2000) overnight on a
shaker at room temperature and then for 3 hr in biotinylated anti-rabbit
antibody (1:200; Vector Laboratories, Burlingame, CA) and for 1 hr in
ExtrAvidin-peroxidase (1:5000; Sigma, St. Louis, MO). Peroxidase was
histochemically visualized with diaminobenzidine. Processed sections
were mounted on gelatin-coated slides and coverslipped with DPX
mountant (BDH Chemicals, Poole, UK).
For immunofluorescence, sections were incubated overnight in pri-
mary antibody (NOS-I or sGC; 1:1000). Immunoreactivity was visual-
ized by donkey IgG, conjugated to FITC (Jackson ImmunoResearch,
West Grove, PA). Sections were mounted on gelatin-coated slides and
directly coverslipped with Vectashield (Vector Laboratories) for viewing
under Nomarski illumination. To control for method specificity, some
sections were processed as above, except that primary or secondary
antibodies were omitted. In all such cases, staining was barely detectable
or completely absent.
Multiple immunofluorescence labeling. Tyramide signal amplification
(TSA) was used to permit multiple labeling with primary antibodies from
a single species (Shindler and Roth, 1996). Fluorescent staining with the
first primary antibody was enhanced with TSA, and conventional fluo-
rescent staining was then performed with the second primary antibody.
We used the first primary antibodies at a concentration so low that
antigen consistently failed to be revealed by a conventional fluorophore-
conjugated secondary antibody (donkey anti-rabbit IgG conjugated to
FITC; 1:200 for 3 hr; Jackson ImmunoResearch) but was still clearly
detectable with TSA. After overnight incubation in primary antibody
(NOS-I, 1:30,000; sGC, 1:15,000; or NR2, 1:10,000), sections were
reacted for 2 hr at room temperature with biotinylated secondary anti-
body (1:200; Jackson ImmunoResearch). Biotin was revealed by FITC
conjugated to tyramide (Renaissance TSA direct kit; DuPont NEN,
Wilmington, DE), according to the manufacturer’s recommendation.
The second primary antibodies were then applied overnight (NOS-I or
sGC; 1:1000). Immunoreactivity was visualized by donkey anti-rabbit
antibody conjugated to Cy3 (Jackson ImmunoResearch). For triple la-
beling, the third primary antibody (raised in a different species than the
first two primary antibodies) was applied overnight [PSD-95 (1:500) or
synaptophysin (1:1000)] and visualized by a secondary antibody conju-
gated to Cy5 (Jackson ImmunoResearch). All secondary antibodies were
multiple labeling grade and had been extensively preadsorbed with
normal serum from other species to prevent inadvertent cross-reaction.
Controls. As emphasized by Shindler and Roth (1996), several control
procedures are necessary to obtain reliable multiple labeling with the
TSA method. Omission of primary or secondary antibodies resulted in
the lack of specific staining in the corresponding channel. Substitution of
preimmune normal serum for primary antibody led to a very weak
Nissl-like pattern of staining. To control for possible cross-reaction
between the first primary antibody and the second secondary antibody,
the second primary antibody was omitted. In such cases, no staining was
observed on the channel corresponding to the second secondary anti-
body. Moreover, we obtained identical results when the order of the two
primary antibodies was reversed.
Visualization of cell processes. To define the relationship between
cellular morphology and immunostaining, we used the lipophilic dye
4-(4-(dihexadecylamino)styryl)-N-methyl pyridinium iodide (DiA) (Mo-
lecular Probes, Eugene, OR), which infiltrates the plasma membrane,
labeling even the finest neuronal processes. DiA crystals were applied
with a micropipette directly to immunostained sections set gently on top
of an agar-filled Petri dish. The dish was then covered and stored at 4°C
for 24–72 hr. Sections were mounted on slides and coverslipped with
Vectashield.
Microscopy and data analysis. Sections were examined with a Leitz
DMR (Wetzlar, Germany) microscope under bright field, Nomarski, or
epifluorescence illumination. Fluorescent images were acquired with a
cooled charge-coupled device (CCD) camera (Princeton Instruments,
Trenton, NJ) coupled to a Macintosh computer. IP Lab software (Scana-
lytics, Fairfax, VA) was used for image acquisition and initial processing.
Table 1. Primary antibodies used in the study
Protein Source Antibody Host Characterized in
NOS-I Zymed Z-RNN Rabbit
sGC (1 subunit) H.H.H.W. Schmidt sa2934 Gua2 Rabbit Zabel et al., 1998, 1999
Synaptophysin Sigma Clone SVP-38 Mouse Devoto and Barnstable, 1989
NR2A/B Chemicon AB1548 Rabbit Petralia et al., 1994
PSD-95 Transduction Laboratories Clone 16 Mouse Derek et al., 1999
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For optimal resolution of thick sections, images were acquired with a
Leica TCS confocal microscope. By following optical sections through
z-axis stacks, it was possible to assess continuity of processes through the
thickness of a tissue section.
Postembedding electron microscopy. For postembedding immunolabel-
ing, sections from three rats, fixed with 2% paraformaldehyde and 2%
glutaraldehyde, were processed for osmium-free embedment in Epon-
Spurr resin according to the method of Phend et al. (1995). Thin (100
nm) sections were collected on nickel mesh grids and processed for
immunogold labeling as described previously (Phend et al., 1992, 1995).
Briefly, after treatment with 4% para-phenylenediamine in Tris-buffered
saline (TBS/T; 0.1 M Tris, pH 7.6, with 0.005% Tergitol Nonidet P-10),
grids were incubated overnight at 37°C in the primary antibody. Grids
were then transferred to TBS/T, pH 8.2, incubated for 1 hr in the
secondary antibody conjugated to 10 nm gold particles (1:15 in TBS/T,
pH 8.2; British BioCell; Ted Pella, Redding, CA), and counterstained
with uranyl acetate and Sato’s lead. Grids were examined on a Philips
Tecnai 12 electron microscope (FEI, Hillsboro, OR) at 80 kV acceler-
ating voltage.
For quantitative study, two thin sections from each of the three rats,
labeled with 10 nm gold particles, were examined. Digital images of
asymmetric synapses that had clearly defined synaptic membranes and
were labeled with at least one gold particle within 100 nm of the
postsynaptic membrane were randomly acquired at 30,000 magnifica-
tion using a CCD camera (Gatan, Pleasanton, CA) attached to the
electron microscope. Locations of gold particles were measured with
Scion Image software version 4.0 (Scion, Frederick, MD). To define
“axodendritic” position, the distance between the center of each gold
particle and the outer leaflet of the postsynaptic membrane was mea-
sured. The distance from each end of the active zone to a line drawn
perpendicular to the synaptic membrane and running through the center
of the particle was used to determine the tangential position of each
particle with respect to the synapse; we used these data to compute the
normalized lateral position, with 0 corresponding to the center of the
active zone and 1 to its edge (Valtschanoff and Weinberg, 2001).
To study colocalization of NOS-I and sGC, serial sections were
collected on successive grids and stained for the two antigens, and then
corresponding regions of each grid were examined. To study colocaliza-
tion on the same thin section, the two antigens were labeled with two
sizes of immunogold, using the same protocol as for single labeling
[NOS-I (1:500) and sGC (1:100)]. Because both antibodies were raised
in the same species, we applied hot formaldehyde fumes to the grids
(80°C for 1 hr) to denature the first primary antibody and minimize
cross-reaction (Phend et al., 1992). When primary antiserum was omitted
as a control, virtually no gold particles could be detected on the section;
when normal serum was substituted for immune serum, sparse gold
particles were scattered across the section.
Digital postprocessing. We used Adobe PhotoShop version 5 (Adobe
Systems, San Jose, CA) and Corel Draw version 10 (Corel, Ontario,
Canada) to sharpen images, balance colors, adjust brightness and con-
trast, and compose final plates. Specific regions of an acquired image
were not selectively processed; all adjustments were applied to the entire
field.
RESULTS
Specificity of the NOS-I antibody
Our laboratory has encountered difficulties using NOS-I antibod-
ies for postembedding gold immunocytochemistry; we presume
that this reflects idiosyncrasies of the NOS-I molecule and its
epitope exposure after fixation and embedment. After extensive
trials, we found that the primary antibody supplied by Zymed
(South San Francisco, CA) (Table 1) performs particularly well.
That the antibody was specific seemed likely, because the overall
pattern of staining with LM resembled that seen with NADPHd
staining and with better-characterized antibodies (Schmidt et al.,
1992). To provide more conclusive evidence, we performed im-
munocytochemistry on material from NOS-I knock-out mice, run
in parallel with material from control mice and rats. For each light
and electron microscopic immunocytochemical procedure re-
ported below, staining in the knock-out mice was extremely weak
and exhibited a “background” pattern unrelated to that seen for
controls (data not shown). Therefore, we conclude that this
antibody specifically recognizes NOS-I when used according to
our protocols.
LM distribution of NOS and sGC after standard fixation
After fixation with 4% paraformaldehyde, the distribution of
NOS-I throughout the hippocampus was as reported previously
using both immunocytochemistry and histochemistry for NAD-
PHd (Vincent and Kimura, 1992; Valtschanoff et al., 1993a; Dun
et al., 1994). At low magnification, diffuse staining extended
throughout the hippocampus, most prominent in the inner third
of the molecular layer of the dentate gyrus, and sparing the
stratum lacunosum moleculare (Fig. 1A1). Immunopositive cells
were most numerous in the subiculum and in the hilar region of
the dentate. In CA1, intense somatodendritic immunostaining
was observed in a small number of interneurons scattered
throughout the pyramidal layer, extending also into other layers
(Fig. 1A2). In contrast, somata of pyramidal neurons were immu-
nonegative or very weakly stained. In the stratum radiatum,
intensely immunoreactive puncta could be seen, especially with
immunofluorescence; we interpret these puncta as dendritic
branches cut in cross section (see below).
At low magnification, the overall pattern of sGC staining
differed from that for NOS-I. Staining was strongest in the sub-
iculum and was prominent also in the neuropil of Ammon’s horn,
sparing the pyramidal cell layer and granule cell layer of the
dentate (Fig. 1B1). At higher magnification, it was clear that
pyramidal and granule cells were unstained, although a small
number of intensely sGC-positive neurons was randomly scat-
tered throughout CA1, among others that stained more weakly
(Fig. 1B2). The pattern of staining was somatodendritic, sparing
the nucleus. Based on their morphology, most of these cells were
likely to be local circuit neurons. Double immunofluorescence
demonstrated that a few of these sGC-positive cells were also
immunopositive for NOS-I (data not shown). Diffuse staining was
seen in the neuropil.
Figure 1. Immunostaining for NOS-I and sGC after fixation with 4%
paraformaldehyde. A1, Staining for NOS-I is in scattered cells and is
denser in the dentate hilus. Neuropil staining is prominent in the dentate
molecular layer and in the stratum radiatum of Ammon’s horn. A2, A
population of nonpyramidal neurons in CA1 stain intensely, in contrast to
unstained somata of pyramidal cells (pyramidal cell layer in the middle,
stratum radiatum toward the bottom). B1, Staining for sGC is intense in
scattered cells and most numerous in CA2; diffuse immunostaining is seen
in the neuropil of Ammon’s horn. B2, In CA1, pyramidal cells are
unstained or very weakly stained, whereas some nonpyramidal cells are
strongly immunopositive. Scale bars: A1, B1, 500 m; A2, B2, 50 m.
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LM distribution of NOS and sGC after weak fixation
Previous results suggest that NOS-I may be difficult to detect after
standard formaldehyde fixation protocols (Wendland et al., 1994;
Gonzalez-Hernandez et al., 1996). This may reflect denaturation
of essential epitopes; alternatively, cross-linking of proteins asso-
ciated with standard fixation protocols may limit antibody access,
especially within the protein-rich PSD, leading to spurious neg-
ative results (cf. Valtschanoff et al., 2000). Therefore, it seemed
possible that many synapses might contain NOS-I that could not
be detected by standard methods. Moreover, the immunostaining
for sGC was at variance with in situ results suggesting that
pyramidal neurons in CA1 express appreciable amounts of this
protein (Matsuoka et al., 1992; Gibb and Garthwaite, 2001).
Therefore, we performed immunostaining on weakly fixed mate-
rial (from rats perfused with 1% paraformaldehyde).
As with standard fixation (4% paraformaldehyde), NOS-I im-
munoreactivity in CA1 was intense in scattered interneurons (Fig.
2A1). However, in contrast to the distribution after standard
fixation, weak to moderate immunoreactivity was also observed
consistently in the somata of numerous pyramidal neurons (Fig.
2A2), extending into dendrites. The difference in sGC immuno-
staining was even more striking. Again, scattered interneurons
were intensely immunopositive (Fig. 2B1), but in contrast to the
“negative staining” after standard fixation, the pyramidal cell
layer of CA1 stood out as immunopositive after weak fixation,
reflecting a moderate level of immunostaining in pyramidal cells
(Fig. 2B2).
LM evidence for synaptic immunostaining after
weak fixation
To assess the distribution of NOS and sGC at synapses, we
performed triple immunolabeling for NOS-I, sGC, and synapto-
physin. Numerous puncta immunoreactive for NOS-I and sGC
were observed in the stratum radiatum (Fig. 3). Punctate staining
was variable in intensity and strongest in profiles likely to be
transversely cut dendrites of interneurons. Consistent with this
interpretation, only a weak relationship was detected between the
brightest puncta and the presynaptic marker synaptophysin. In
contrast, a close relationship was observed between many of the
more weakly immunoreactive puncta and synaptophysin, suggest-
ing that both NOS-I and sGC are present at synapses (Fig. 3,
circles).
We examined this triple-labeled material under conditions of
optimal resolution (confocal microscopy using a small pinhole
and high numerical aperture oil immersion objective), attempting
to distinguish puncta that overlapped in two channels, from
puncta that were adjacent. For NOS-I, 19% (13 of 75) of
synaptophysin-related puncta were judged to overlap the synap-
tophysin puncta, whereas 81% (62 of 75) were judged to lie
adjacent; in contrast, for sGC, 72% (65 of 89) of synaptophysin-
related puncta were judged to overlap the synaptophysin, whereas
only 28% (24 of 89) lay adjacent (Table 2). Thus, sGC-positive
puncta were significantly more likely to overlap synaptophysin
puncta than were NOS-I puncta ( p  0.01; paired two-sided t
test). Although the limited resolution of light microscopy prevents
definite conclusions, these data are consistent with the hypothesis
that sGC concentrates in axon terminals, whereas NOS-I concen-
trates in postsynaptic densities.
Quantitative examination revealed that 8% of synaptophysin-
Figure 2. Immunostaining for NOS-I and sGC after fixation with 1%
paraformaldehyde. A1, As for material fixed with 4% paraformaldehyde,
a few nonpyramidal neurons scattered throughout the hippocampal for-
mation were intensely immunopositive. A2, Higher magnification revealed
immunostaining also in the cytoplasm of numerous CA1 pyramidal cells,
at variance with the image seen after stronger fixation (Fig. 1A2). B1,
Scattered cells were strongly immunopositive for sGC. At low magnifi-
cation, the pyramidal cell layer of CA1 stood out as diffusely immunopo-
sitive, at variance with the image seen after stronger fixation. B2, Higher
magnification showed immunostaining for sGC in the cytoplasm of a
large number of CA1 pyramidal cells. Scale bars: A1, B1, 500 m; A2, B2,
50 m.
Figure 3. Triple immunofluorescence for NOS-I (blue), sGC ( green), and the presynaptic marker synaptophysin (Syn, red), in the stratum radiatum
of CA1. Examples of puncta double stained for sGC and synaptophysin, apposed to puncta stained for NOS-I, are circled. Contrast is enhanced in the
triple-labeled panel (right) to facilitate identification of multiple labeling. Scale bar, 10 m.
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positive puncta were NOS-I positive, and 9% of synaptophysin-
positive puncta were sGC positive (Table 2). These double-
labeled puncta are likely to be NOS-positive and sGC-positive
synapses, respectively. We hypothesized that these two elements
of the NO signaling pathway might be specifically related, such
that sGC-positive axon terminals are selectively presynaptic to
NOS-positive PSDs. Supporting this hypothesis, 52% of the NOS-
positive synaptic puncta also expressed sGC, and 64% of sGC-
positive synaptic puncta also expressed NOS (Table 2). If we
restricted consideration to sGC puncta overlapping synaptophy-
sin puncta and NOS puncta adjacent to synaptophysin puncta, the
selectivity was even more striking; 74% of NOS-positive puncta
also expressed sGC, and 81% of sGC-positive puncta also ex-
pressed NOS. This suggests that a subpopulation of synapses in
the stratum radiatum are biochemically specialized to use the
NO–sGC signaling pathway.
To investigate more directly the relationship between NOS-I
and sGC in dendritic spines, we used the lipophilic tracer DiA to
label the dendritic plasma membrane of CA1 pyramidal cells.
Double immunostaining performed in this material demonstrated
that numerous spines in the stratum radiatum contained NOS-I.
In many cases, a clear relationship could be seen between NOS-
positive spines and adjacent sGC-stained puncta (Fig. 4).
NOS-I is preferentially activated by calcium influx through
NMDA receptors, at least in cultured neurons (Kiedrowski et al.,
1992). This special relationship between NMDA receptor-
mediated calcium influx and NOS-I activation suggests that the
receptor may be physically coupled to the enzyme. In view of
biochemical evidence that NMDA receptors and NOS-I can be
linked together by the adaptor protein PSD-95 (Christopherson
et al., 1999; Sattler et al., 1999; Tochio et al., 2000; Valtschanoff
Figure 4. NOS-I and sGC in dendritic spines. The lipophilic dye DiA ( green), which stains the entire plasma membrane of scattered CA1 pyramidal
neurons, allows appreciation of the relationship of antigen to dendrites and dendritic spines. A (top panel ), Low-magnification overview of the
relationship of immunostaining for NOS-I (red) and sGC (blue) with apical dendrites of pyramidal neurons stained with DiA. B, C, High-magnification
views of boxed areas. Arrowheads point to dendritic spines immunopositive for NOS-I, associated with puncta immunopositive for sGC. Scale bars: A,
10 m; B, 2.5 m; C, 2 m.
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and Weinberg, 2001), and previous evidence from cerebral cortex
(Aoki et al., 1998), we wondered whether the three proteins
actually colocalize in the hippocampus. Using triple immuno-
staining, we found that NR2 in the stratum radiatum colocalized
with PSD-95 and NOS-I (Fig. 5A); examination at higher magni-
fication showed that this colocalization was in puncta, which in
some cases could be identified as dendritic spines (Fig. 5B).
Ultrastructural distribution of NOS and sGC
The above data demonstrate a spatial association between NOS-
I-positive and sGC-positive puncta and support the possibility
that NOS lies within the PSD at excitatory synapses, immediately
postsynaptic to sGC-positive axon terminals, an arrangement that
would suggest a role for NO as retrograde messenger. However,
to answer this question unequivocally is beyond the limit of
resolution of light microscopy, and pre-embedding EM is inher-
ently limited by variable antibody penetration (Griffiths, 1993). To
provide optimal spatial resolution and maintain uniform access to
antibody, we performed postembedding electron microscopy. A
few aspiny dendritic profiles, presumably arising from NOS-
positive interneurons, were immunopositive. Immunogold parti-
cles coding for NOS-I concentrated over the postsynaptic density
of axospinous synapses of asymmetric type (Fig. 6A). In contrast,
sGC labeling was concentrated over the presynaptic terminals of
asymmetric axospinous synapses (Fig. 6B). Quantitative EM of
randomly selected asymmetric synapses in the stratum radiatum
confirmed that gold particles coding for NOS-I were predomi-
nantly postsynaptic, concentrating just cytoplasmic to the
postsynaptic membrane, whereas particles coding for sGC were
predominantly presynaptic, concentrating 15–25 nm cytoplas-
mic to the presynaptic membrane (Fig. 6C).
The distributions of NOS-I and sGC suggest that the two
enzymes might be present on the two sides of the same synapses.
To test this hypothesis, we examined sections double labeled
using two sizes of gold particles. To control for possible cross-
reactivity (because the two primary antibodies were raised in the
same species), we also studied serial single-labeled sections. De-
spite the vagaries of these methods, we were able to demonstrate
NOS-I-positive PSDs postsynaptic to sGC-positive terminals,
using both techniques (Fig. 6D–F).
Because postembedding immunogold is thought to provide an
unbiased estimate of antigen distribution, these data can be taken
to demonstrate that a large fraction of the NOS-I in the general
region of the synaptic apposition is intimately associated with the
PSD and likewise that a large fraction of the sGC lies very close
to the presynaptic active zone. Because most potential antigenic
sites are occluded by the plastic resin, postembedding data may
suffer from false negatives and are therefore not well suited to
determine the quantitative relationship between sGC-positive
terminals and NOS-I-positive dendrites. However, in light of the
spatially accurate immunogold data, the immunofluorescence
data of Table 2 support a precise trans-synaptic relationship
between the two proteins.
Figure 5. Triple immunofluorescence for NR2 ( green), NOS-1 (red), and
PSD-95 (blue). A, CA1 pyramidal cells express all three proteins. NR2
stains somata and proximal dendrites, although puncta in the neuropil are
also visible; staining for PSD-95 is almost exclusively punctate, and NOS-I
shows an intermediate staining pattern. B, High-magnification views of
4
the material shown in A reveal that some spines visible with NR2 staining
label also for both PSD-95 and NOS-I (arrowheads). Triple-stained puncta
are also visible in the neuropil (arrow); however, in this material, it is
impossible to determine whether these puncta are associated with den-
dritic spines. Contrast is enhanced in the bottom panel to facilitate
identification of multiple labeling. Scale bars: A, 50 m; B, 3 m.
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DISCUSSION
Here we confirm previous results on the cellular and subcellular
organization of NOS-I, showing with quantitative immunogold
methods that this enzyme concentrates at the postsynaptic den-
sity of axospinous synapses in the stratum radiatum of CA1. We
also show that the sGC, a major target for nitric oxide, concen-
trates in presynaptic terminals close to the active zone. Finally,
we show evidence for a precise trans-synaptic organization, so
that although only a modest fraction of synapses express either
NOS-I or sGC, NOS-positive PSDs are usually postsynaptic to
sGC-positive axon terminals and vice versa.
Methodological issues
Many immunocytochemical studies have failed to detect NOS-I in
hippocampal pyramidal neurons, notwithstanding reports sug-
gesting that the antigen may be present (albeit at low levels) in
these cells (Bredt et al., 1991; Chiang et al., 1994; Endoh et al.,
1994; Wendland et al., 1994; Lin and Totterdell, 1998). The
suggestion that NOS-III may be expressed by CA1 pyramidal
neurons (Dinerman et al., 1994; O’Dell et al., 1994) has not been
confirmed. We speculate that this finding may have arisen from
cross-reacting antibodies, because: (1) other NOS-III antibodies
fail to stain pyramidal cells, (2) when performed according to the
protocol of Dinerman et al. (1994), NADPHd histochemical
staining (which detects both NOS-I and NOS-III) stains pyrami-
dal neurons of NOS-III knock-out mice (Weinberg et al. 1994),
and (3) single-cell reverse-transcription PCR reveals a message
for NOS-I but not NOS-III in pyramidal neurons (Chiang et al.,
1994).
In contrast to the selective immunostaining of interneurons
seen with traditional methods, we confirm previous reports that
CA1 pyramidal cells stained for NOS-I after weak fixation
(Wendland et al., 1994); moreover, our methods, which have been
optimized to detect synaptic staining, reveal NOS-I in dendritic
spines. Standard LM immunocytochemical methods may fail to
reveal proteins known to concentrate at the PSD, whereas these
apparently immunonegative synapses stain robustly after weak
fixation or after proteolytic treatment (Watanabe et al., 1998;
Burette et al., 1999; Fukaya and Watanabe, 2000; Burette et al.,
2001b). We conclude that the highly concentrated protein matrix
of the PSD blocks antibody access after the cross-linking induced
by standard aldehyde fixation, in contrast to postembedding meth-
ods, which expose the entire surface of the section to antibody
(Kellenberger and Hayat, 1991; Griffiths, 1993). Considering the
biochemical evidence that NOS may be tightly complexed with
other proteins, difficulties in detecting NOS-I at the synapse are
not unexpected.
Several laboratories have reported that CA1 pyramidal neurons
do not stain for NADPHd (Vincent and Kimura, 1992;
Valtschanoff et al., 1993a). However, NADPHd staining requires
subjective interpretation; pyramidal cell somata do stain if tissue
is incubated long enough in the reaction medium (Weinberg et
al., 1994). The difference in staining density with NADPHd in
Figure 6. Postembedding immunogold labeling for NOS-I and sGC in the stratum radiatum of CA1. A, Synaptic labeling for NOS-I concentrates at
the postsynaptic density of an axospinous synapse of asymmetric type. B, Labeling for sGC concentrates at the presynaptic active zone. C, Positions
of 144 gold particles coding for NOS-I and 82 particles coding for sGC within 150 nm of the postsynaptic membrane were measured relative to the
postsynaptic membrane of randomly sampled synapses in CA1. The axodendritic graph (digitally smoothed) shows that labeling density for NOS-I peaked
at the postsynaptic membrane, extending into the postsynaptic profile, whereas labeling for sGC concentrated at the presynaptic membrane. Inset,
Labeling close to the plasma membrane concentrated at the synaptic specialization for both antigens. Double immunogold labeling (D) and single
labeling on serial sections (E, F ) document that NOS-positive PSDs were postsynaptic to sGC-positive axon terminals. Scale bars, 0.2 m.
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interneurons versus pyramidal neurons is so great that to obtain
optimal staining in interneurons, one must stop the reaction
before it reveals possible traces of NOS in pyramidal neurons.
Notwithstanding the controversy about pyramidal cells, there is
general agreement that the neuropil of the stratum radiatum is
diffusely positive for NADPHd; in light of our results, this seems
likely to represent synaptic staining. Because NADPHd may not
stain NOS itself but instead a cofactor (e.g., tetrahydrobiopterin)
(Reif et al., 1999; Pantke et al., 2001), we hypothesize that
concentration of cofactor selectively in the neuropil may account
for the apparent discrepancy.
Supramolecular organization of the NO signaling
pathway across the synapse
Current evidence suggests a heterogeneous assembly of supramo-
lecular complexes within the PSD (Nusser et al., 1994; Kharazia
and Weinberg, 1997; Ottersen and Landsend, 1997; Kennedy,
2000; Husi and Grant, 2001). Immunogold EM demonstrates that
NOS-I concentrates in the postsynaptic density in the neocortex,
close to the NMDA receptor complex (Aoki et al., 1993, 1997,
1998; Valtschanoff and Weinberg, 2001), pointing to the impor-
tance of PSD-95 as a scaffold molecule helping to organize this
signaling pathway (cf. Migaud et al., 1998; Sattler et al., 1999).
Here we confirm the postsynaptic concentration of NOS-I in the
stratum radiatum of CA1. Importantly, we also show that sGC
concentrates in terminals presynaptic to these NOS-I and NMDA
receptor-expressing spines. Recent evidence suggests that sGC
may concentrate immediately subjacent to the plasma membrane
also in non-neuronal tissues (Feussner et al., 2001; Zabel et al.,
2002). We speculate that sGC may interact with a presynaptic
scaffold molecule anchored to the presynaptic plasma membrane
(Russwurm et al., 2001).
The colocalization of NOS-I with NMDA receptors and
PSD-95 demonstrated here is likely to reflect juxtaposition at the
molecular scale (Brenman et al., 1996; Christopherson et al.,
1999; Valtschanoff and Weinberg, 2001). We show that NOS
concentrates at the PSD, whereas sGC concentrates close to the
plasma membrane of the presynaptic terminal. Although only
8–9% of synapses were immunopositive for each antigen,
50% of those staining for NOS stained also for sGC and vice
versa. Considering the technical limitations of our methods, the
present results are likely to underestimate the true extent of this
correspondence.
A role for NO in retrograde signaling and
synaptic plasticity?
The relative functional significance of presynaptic and postsyn-
aptic loci in mediation of LTP remains controversial; different
subcellular loci may predominate under different experimental
circumstances. The role of NO in hippocampal plasticity also
remains controversial, with different groups reporting major ef-
fects, minor effects, no effects, or effects in some but not other
experimental conditions. The most convincing experiments have
been performed in models that may be far removed from the
intact adult hippocampus. Based on current knowledge, a large
number of distinct mechanisms might play a role in LTP (Sanes
and Lichtman, 1999), but their relative contributions to synaptic
plasticity in the adult brain remain to be established. Our data
suggest that NO may mediate LTP in a specific subpopulation of
CA1 synapses in the adult hippocampus.
A population of hippocampal interneurons expresses NOS-I
throughout their cytoplasm. NO released by these interneurons
seems poorly suited on anatomical grounds to mediate homosyn-
aptic plasticity but might play a more global role (Gally et al.,
1990; Valtschanoff et al., 1993b). Indeed, under some circum-
stances, synaptic potentiation can be diffuse (Bonhoeffer et al.,
1989; Engert and Bonhoeffer, 1997), and experimental evidence
suggests that NO may mediate diffuse potentiation (Madison and
Schuman, 1995), perhaps acting as a permissive signal. NO from
these interneurons may also play a role in local regulation of
blood flow, along with NO synthesized by NOS-III in the vascular
endothelium (Loesch and Burnstock, 1996; Estrada and DeFe-
lipe, 1998). Conversely, considering evidence from NOS-III
knock-out mice (Son et al., 1996; Wilson et al., 1999), we specu-
late that NO synthesized in the local vascular endothelium may
act as a region-specific permissive signal in some forms of synap-
tic plasticity.
Notwithstanding these possible diffuse effects, perhaps the
most salient feature of synaptic plasticity in CA1 is its spatial
precision; LTP in the Schaffer collateral pathway is widely be-
lieved to be predominantly homosynaptic. Thus, it seems puzzling
that NO, a toxic and freely diffusible gas, could mediate this
plasticity. We suggest that anatomical features of the signaling
pathway may explain this apparent paradox. The concentration of
material diffusing from a point source falls off rapidly with dis-
tance (Carslaw and Jaeger, 1959); because NO is unstable, its
concentration will decline even more sharply. Thus, the spatial
organization of NOS-I and sGC in pyramidal neurons reported
here could be expected to enhance transduction speed while
keeping the retrograde signal focused on a single synapse.
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